Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis (MS)”

1,040 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,040 results

Testing effectiveness (Phase 2)Looking for participantsNCT07002034
What this trial is testing

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Who this might be right for
Adjustment Disorder
Reunion Neuroscience Inc 100
Post-approval studies (Phase 4)Ended earlyNCT02241785
What this trial is testing

Natalizumab as an Efficacy Switch in Participants With Relapsing Multiple Sclerosis After Failure on Other Therapies

Who this might be right for
Relapsing Multiple Sclerosis
Biogen 47
Not applicableStudy completedNCT00618267
What this trial is testing

ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.

Who this might be right for
Multiple Sclerosis
Biogen 100
Post-approval studies (Phase 4)Active Not RecruitingNCT05090371
What this trial is testing

Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Novartis Pharmaceuticals 136
Large-scale testing (Phase 3)Looking for participantsNCT05834855
What this trial is testing

Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingDemyelinating Autoimmune Diseases, CNS+3 more
Amsterdam UMC, location VUmc 200
Large-scale testing (Phase 3)Study completedNCT00681538
What this trial is testing

The Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)

Who this might be right for
SpasticityMultiple Sclerosis
Jazz Pharmaceuticals 572
Not applicableLooking for participantsNCT05516537
What this trial is testing

Examining the Effects of a Remotely-delivered, Racially-tailored Exercise Training Program for Immediate and Sustained Improvements in Walking Dysfunction, Symptoms, and Health-related Quality of Life (HRQOL) Among African-Americans With Multiple Sclerosis (MS) Residing in Rural Environments.

Who this might be right for
Multiple Sclerosis
University of Illinois at Chicago 100
Not applicableUnknownNCT05783999
What this trial is testing

Muscle Vibration and Fatigue in Patients With MS

Who this might be right for
Multiple Sclerosis
IRCCS Centro Neurolesi Bonino Pulejo 20
Testing effectiveness (Phase 2)Study completedNCT02542787
What this trial is testing

Study of VSN16R for the Treatment of Spasticity in Multiple Sclerosis

Who this might be right for
Spasticity in People With Multiple Sclerosis
Canbex Therapeutics Ltd 160
Not applicableLooking for participantsNCT07135752
What this trial is testing

Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological Examination

Who this might be right for
Radiologically Isolated Syndromes; Multiple Sclerosis
Centre Hospitalier Universitaire de Nice 150
Testing effectiveness (Phase 2)Study completedNCT00333138
What this trial is testing

Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Novartis 281
Not applicableStudy completedNCT01097538
What this trial is testing

Study of Alternative Exercise Therapies for Progressive Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Hicks, Audrey, Ph.D. 10
Not applicableStudy completedNCT01335633
What this trial is testing

Psychometric Validation of Cognitive Endpoints

Who this might be right for
Multiple Sclerosis
Kessler Foundation 60
Not applicableStudy completedNCT04122989
What this trial is testing

Validation of a Shared Decision-Making Tool for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Shared Decision Making Resources 501
Not applicableStudy completedNCT01978574
What this trial is testing

Intellectual Enrichment to Build Cognitive Reserve in MS

Who this might be right for
Cognitive Impairment in Multiple Sclerosis
Kessler Foundation 9
Not applicableStudy completedNCT05437276
What this trial is testing

A Therapeutic Experience Program (TEP) Study for Improvement of Gait in People With Multiple Sclerosis (MS)

Who this might be right for
Gait Impairment Due to Mild/Moderate Multiple Sclerosis (MS)
Helius Medical Inc 43
Not applicableStudy completedNCT01925690
What this trial is testing

Development of a Motivational Intervention to Improve Treatment Adherence in MS

Who this might be right for
Relapsing-remitting Multiple Sclerosis
University of Missouri, Kansas City 80
Testing effectiveness (Phase 2)WithdrawnNCT03000127
What this trial is testing

Testosterone for Fatigue in Men With MS

Who this might be right for
Multiple Sclerosis
University of California, Los Angeles
Not applicableStudy completedNCT04498286
What this trial is testing

COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Zoé van Kempen 546
Not applicableStudy completedNCT04175418
What this trial is testing

The Effects of Two Different Types of Exercise Programs to Increase Physical Activity in Patients With MS

Who this might be right for
Multiple Sclerosis
Istanbul University - Cerrahpasa 21
Load More Results